Not All Albumins Are Created Equal: Elevate Your Raw Material Strategy
Time: 11:45 am
day: Conference Day One
Details:
- Discover why consistent, well-characterized albumin is critical for reproducible advanced therapy (AT) manufacturing
- Explore how high-quality recombinant alternatives offer enhanced purity and support reproducible manufacturing and regulatory confidence in AT development
- Understand how strategic material choices improve product quality, simplify regulatory pathways, enable standardized sourcing strategies, and enhance supply chain resilience
